BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 210 filers reported holding BRIDGEBIO PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,263,883 | -7.5% | 313,382 | -39.6% | 0.05% | -2.0% |
| Q2 2023 | $8,931,031 | +57.8% | 519,246 | +52.1% | 0.05% | +31.6% |
| Q1 2023 | $5,658,422 | +3.2% | 341,280 | -52.6% | 0.04% | -17.4% |
| Q4 2022 | $5,480,830 | -6.7% | 719,269 | +21.8% | 0.05% | -25.8% |
| Q3 2022 | $5,872,000 | +42.7% | 590,740 | +30.4% | 0.06% | +63.2% |
| Q2 2022 | $4,114,000 | -35.0% | 453,080 | -27.3% | 0.04% | +2.7% |
| Q1 2022 | $6,326,000 | +160.3% | 623,202 | +327.7% | 0.04% | +184.6% |
| Q4 2021 | $2,430,000 | -16.2% | 145,704 | +135.5% | 0.01% | -35.0% |
| Q3 2021 | $2,900,000 | +16.6% | 61,881 | +51.7% | 0.02% | +25.0% |
| Q2 2021 | $2,487,000 | -14.0% | 40,803 | -13.1% | 0.02% | -20.0% |
| Q1 2021 | $2,892,000 | +167.5% | 46,950 | +209.0% | 0.02% | +81.8% |
| Q4 2020 | $1,081,000 | -34.9% | 15,196 | -65.7% | 0.01% | -45.0% |
| Q3 2020 | $1,660,000 | +52.9% | 44,255 | +32.9% | 0.02% | +33.3% |
| Q2 2020 | $1,086,000 | +60.9% | 33,309 | +73.1% | 0.02% | +50.0% |
| Q4 2019 | $675,000 | – | 19,248 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
| M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
| Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
| HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
| Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
| Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
| Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
| HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |